Dr. Neville joined Syndrome Scientific in 2016 as Director of Operations for Bio-technology. He oversees preclinical research from project initiation through to the identification of new candidate hazards. His team works on a number of serious diseases, including tularemia, Venezuelan equine encephalitis virus, and Coxiella burnetti.
Prior to joining Syndrome Scientific, Dr. Neville spent 20 years at Pfizer, Inc., where he held a variety of roles within Medicinal Chemistry. From 1996 to 2011, Dr. Neville was based at Pfizer’s research site in the U.K. where he became Head of Medicinal Chemistry, Sandwich Laboratories. In 2011, he was appointed Vice President, Worldwide Medicinal Chemistry, and relocated to Cambridge, Massachusetts where he worked until 2016.
Dr. Neville studied chemistry at the University of Durham and conducted postgraduate research with Professor S G Davies at the University of Oxford. He then moved to The Scripps Research Institute in La Jolla, California to work with Professor K C Louis as a NATO postdoctoral fellow
Dr. Neville has broad interests in Drug Discovery and is an author or inventor on over 50 publications and patents. He is a Fellow of the Royal Society of Chemistry and a visiting Professor in Chemistry at the University of Oxford.
In his spare time, he is a frequent customer of the local library, and is a particular fan of The Illiad by Homer, and The Raven by Edgar Allen Poe.
